ELV Elevance Health, Inc. Common Stock

NYSE · Health Care · Wyświetl na SEC EDGAR ↗
$400,48
Cena · Sie 19, 2026
Dane fundamentalne na dzień Lip 15, 2026

O Elevance Health, Inc. Common Stock Przegląd firmy z Wikipedii

Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.

Czytaj więcej

Elevance Health, Inc. is an American health insurance company. Prior to June 2022, Elevance Health was named Anthem, Inc. The company is the world's seventh largest healthcare company based on revenue. Its services include medical, pharmaceutical, dental, behavioral health, long-term care, and disability plans through affiliated companies such as Anthem Blue Cross and Blue Shield, Anthem Blue Cross in California, Wellpoint, and Carelon. It is the largest for-profit managed health care company in the Blue Cross Blue Shield Association. As of 2022, the company had 46.8 million members within its affiliated companies' health plans.

Based on its 2021 revenues, the company ranked 20th on the 2022 Fortune 500. In 2023, the company's seat in Forbes Global 2000 rankings was 78. Carelon Global Solutions, Elevance Health's Business Process Outsourcing (BPO)/Shared Services subsidiary, serves the group's offshore and customer service management. It operates sites in India, Puerto Rico, Philippines, and the United States.

History

Anthem

In 1946, Anthem began in Indianapolis, Indiana, as Mutual Hospital Insurance Inc. and Mutual Medical Insurance Inc. The companies grew significantly, controlling 80% of the medical insurance market in Indiana by the 1970s.

In 1972, the two firms, then known as Blue Cross of Indiana and Blue Shield of Indiana, entered into a joint operating agreement.

In 1985, the two companies merged into Associated Insurance Companies, Inc,, later called, The Associated Group, a holding company, but usage of the name "Anthem" persisted. In 1989, the company purchased American General Insurance Co. for $150 million and in 1991, it acquired The Shelby Insurance Co., based in Shelby, Ohio, for $125 million. In 1989, The Associated Group founded Acordia, a brokerage that sold and serviced insurance and employee benefit programs.

In 1993, Acordia acquired American Business Insurance for $130 million and the Federal Kemper Insurance Company for $100 million. The Associated Group merged with Southeastern Mutual Insurance Company, the operator of Blue Cross and Blue Shield of Kentucky. In 1994, it sold Raffensperger, Hughes & Co., Inc., Indiana's largest investment bank, to National City Corp.

In 1995, The Associated Group acquired Community Mutual Insurance, a provider of Blue Cross and Blue Shield insurance plans in Ohio with over 1.9 million policy holders), then set up Anthem Blue Cross and Blue Shield. In 1996, The Associated Group changed its name to Anthem Insurance Company. In August 1997, Anthem acquired Blue Cross and Blue Shield of Connecticut. It also sold Acordia to management.

In 1999, Anthem acquired Blue Cross and Blue Shield of New Hampshire and Blue Cross and Blue Shield of Colorado and Nevada, using debt financing. The acquisitions made since 1996 added 850,000 policy holders. Among its customer base were 2.4 million PPO and 964,000 HMO enrollees.

In 2000, Anthem acquired Blue Cross Blue Shield of Maine. The Gramm-Leach-Bliley Act of 1999 made it possible for Anthem to undergo demutualization and become a public company via an initial public offering, which made it the fourth largest public managed health care company in the United States.

In 2002, Anthem acquired Trigon Healthcare of Virginia, a Blue Cross and Blue Shield plan, the largest insurer in Virginia, for $4.04 billion. Anthem Insurance Company reached 11.9 million members.

Blue Cross of California

Blue Cross of California was the predecessor of WellPoint Health Network Inc.

In 1982, Blue Cross of California was founded with the consolidation of Blue Cross of Northern California (established in 1936) and Blue Cross of Southern California (established in 1937).

In 1992, WellPoint was formed to operate Blue Cross of California's managed care business. In January 1993, Blue Cross of California spun off its managed care business into a publicly traded entity, WellPoint Health Networks Inc. Blue Cross of California retained an 80% interest and voting control.

In 1996, Blue Cross of California restructured to a for-profit corporation, designating WellPoint Health Networks Inc. as the parent organization. In April 1996, WellPoint completed its acquisition of Massachusetts Mutual Life Insurance Company's group life and health insurance subsidiaries for approximately $380 million, making it the second largest publicly held managed health company in the U.S. with 4 million policyholders.

In March 1997, WellPoint acquired the group health and life businesses of John Hancock Financial for $86.7 million. With this acquisition, WellPoint expanded its presence into Michigan, Texas, and the mid-Atlantic, and gained a unit that concentrated on serving the needs of large employers.

In 2000, WellPoint acquired PrecisionRx, a mail service pharmacy fulfillment center in Texas. In March 2000, WellPoint acquired Rush Prudential Health Plans, a Chicago provider, for $204 million. In March 2001, WellPoint acquired Cerulean Companies, the parent company of Blue Cross Blue Shield of Georgia. In 2001, WellPoint offered to acquire CareFirst BlueCross BlueShield for $1.37 billion, including $119 million in bonuses to Carefirst executives. In 2003, the offer was rejected by the Maryland insurance commissioner.

In 2002, WellPoint acquired RightChoice Managed Care, a Missouri-based company that ran Blue Cross and Blue Shield for part of the state, for $1.5 billion. RightChoice also owned provider network company HealthLink. WellPoint also acquired MethodistCare of Houston, Texas and HealthLink. In 2003, WellPoint acquired Golden West Dental and Vision of Camarillo, California, and Cobalt, including Blue Cross and Blue Shield United of Wisconsin.

In November 2004, Wellpoint, Inc. was formed by the merger of Anthem Insurance Company and WellPoint Health Networks Inc. The merger was structured as Anthem acquiring WellPoint Health Networks and renaming itself WellPoint, Inc. WellPoint continued to use 'Anthem' as the brand name under which it operated. It sold its Blue Cross and Blue Shield products in 11 states.

In 2005, WellPoint acquired Alexandria, Virginia–based Lumenos, a provider of consumer-driven health care, for $185 million. Lumenos was the pioneer and market leader in consumer-driven health plans. In December, WellPoint acquired WellChoice, a New York City-based Blue Cross Blue Shield provider, for approximately $6.5 billion, making New York the 14th state in which WellPoint is a Blue Cross Blue Shield licensee.

In 2007, WellPoint acquired Chicago-based American Imaging Management, a radiology benefit management company that creates software to help physicians choose cost-effective locations for their patients to receive medical imaging tests. WellPoint also acquired Chicago-based American Imaging Management (AIM), the leading radiology benefit management company.

In January 2008, Leslie Margolin became the president of California operations. She resigned in July 2010. In 2008, WellPoint acquired Resolution Health, a firm that analyzes patient history for potential medical problems such as adverse drug interactions. In 2009, WellPoint acquired DeCare Dental, a dental insurance firm.

In 2011, WellPoint acquired CareMore, a Cerritos, California-based provider of insurance and care centers for elderly patients. In 2012, WellPoint acquired Amerigroup for $4.9 billion, anticipating significant growth due to Medicaid expansion under the Patient Protection and Affordable Care Act. In August 2012, CEO Angela Braly resigned due to pressure from investors.

On August 13, 2014, WellPoint announced it intended to change its name to Anthem, Inc., effective in December.

Anthem, Inc.

In February 2015, the company acquired Simply Healthcare Holdings, a Medicaid and Medicare managed care company based in Florida. In June 2015, Anthem made an offer to acquire Cigna for more than $54 billion in cash and stock. In February 2017, United States district court Judge Amy Berman Jackson blocked the Cigna merger on grounds of anti-competitive practices. On February 14, Cigna called off its merger agreement with Anthem.

In October 2017, Anthem announced that it would not renew its pharmacy benefit management (PBM) relationship with Express Scripts saying it had been overcharged $3 billion and that instead, Anthem would eventually handle the PBM process itself through its new IngenioRx unit. Anthem announced that it would enter a 5-year contract with CVS Health. Cigna then announced plans in March 2018 to acquire Express Scripts for $58 billion. On November 6, 2017, Gail Koziara Boudreaux was named CEO. In 2018, the company announced a $20 million expansion of its headquarters and the signing of a lease in Atlanta for its technology center. In March 2020, Anthem announced the acquisition of Beacon Health Options, and independently held behavioral health organization.

On February 2, 2021, Anthem announced the acquisition of InnovaCare Health's Puerto Rico subsidiaries including MMM Holdings, LLC ("MMM") and its Medicare Advantage (MA) plan MMM Healthcare, LLC as well as affiliated companies and Medicaid plan. In November 2021, Anthem announced the acquisition of Integra Managed Care in New York. The acquisition of the New York-based international health insurance company was completed on May 5, 2022.

On June 28, 2022, Anthem announced a change of its corporate name to Elevance Health, Inc. and also changed its stock ticker symbol from "ANTM" to "ELV".

Elevance Health

On January 23, 2023, Elevance announced that it entered a definitive agreement to acquire Blue Cross and Blue Shield of Louisiana, increasing Elevance's footprint to 15 states and adding 1.9 million new members. In 2023, Elevance announced that it would rebrand its Amerigroup business as Wellpoint starting in 2024.

As of 2025, Elevance subsidiaries Carelon Behavioral Health and Anthem Blue Cross and Blue Shield are the subject of three lawsuits in New York and Connecticut alleging that they operate ghost networks.

Subsidiaries

Elevance Health includes the following subsidiaries:

Amerigroup

District of Columbia (Medicaid)

Georgia (Medicaid)

New Mexico (Medicare Advantage)

Anthem Blue Cross

California

Blue Cross of California Partnership Plan (Medicaid)

New York (upstate)

Anthem Blue Cross Blue Shield

Colorado

Connecticut

Georgia

Indiana (includes Medicaid)

Kentucky

Anthem Blue Cross and Blue Shield Medicaid

Maine

Missouri (excluding 30 counties in the Kansas City area)

Nevada

Anthem Blue Cross and Blue Shield Healthcare Solutions (Medicaid)

New Hampshire

New York (downstate)

HealthPlus (Medicaid)

Ohio

Virginia (excluding Alexandria City, Arlington County, Falls Church City, and parts of Fairfax County)

HealthKeepers (Medicaid)

Wisconsin

Carelon Behavioral Health

Carelon Behavioral Health of California

Carelon Behavioral Health of Kansas

Carelon Health of Pennsylvania

Carelon Global Solutions (Business Process Outsourcing/Shared Services)

Freedom Health

Florida

Golden West Dental & Vision

California

HealthSun

Florida

MMM

Puerto Rico

Optimum Healthcare

Florida

Simply Healthcare

Florida

UniCare

West Virginia

WellPoint

Arizona (Medicare Advantage)

Iowa (Medicaid and Medicare Advantage)

Maryland (Medicaid)

Massachusetts (government employees)

New Jersey (Medicaid and Medicare Advantage)

Tennessee (Medicaid and Medicare Advantage)

Texas (Medicaid and Medicare Advantage)

Washington (Medicaid and Medicare Advantage)

Joint ventures

Elevance Health operates joint ventures including:

Anthem | MaineHealth (with MaineHealth)

Maine

Blue Medicare Advantage (with Independence Blue Cross)

Pennsylvania

Colorado Community Health Alliance (with Centura Health, Physician Health Partners and Primary Physician Partners)

Colorado

Healthy Blue Kansas (with Blue Cross and Blue Shield of Kansas and Blue Cross and Blue Shield of Kansas City)

Kansas

Healthy Blue Louisiana (with Blue Cross Blue Shield of Louisiana)

Louisiana

Summit Community Care

Arkansas

Centers Plan for Healthy Living

New York, Florida

Quality of care

In 2011, in the category of "Meeting National Standards of Care," California's state patient advocacy office gave Anthem a rating of 2 out of 4 stars. In 2014, it received 3 out of 4 stars in the same category. In 2022, twenty-one of Elevance Health's affiliated Medicaid plans earned accreditation for health equity from the National Committee for Quality Assurance (NCQA).

Controversies

Charitable donations

In 2007, WellPoint pledged to spend $30 million over three years, through the company's charitable foundation, to help the uninsured. In March 2010, the Los Angeles Times reported that WellPoint's tax records and website showed that the company had given only $6.2 million by 2009. The company said that the foundation had indeed fulfilled its $30-million commitment by mid-2009, but refused to provide any financial details to support its claim.

2007 DMHC investigation

In 2007, the California Department of Managed Health Care (DMHC) investigated Anthem's policies for revoking (rescinding) health care insurance policies. The DMHC randomly selected 90 instances where Anthem canceled the insurance of policy holders who had been diagnosed with costly or life-threatening illnesses, to find how many of these cancellations were legal. The agency concluded that all these cancellations were illegal.

In July 2008, Anthem Blue Cross agreed to a settlement with the California Department of Managed Health Care; however in doing so, WellPoint did not officially admit liability. To resolve allegations of improper policy rescissions (cancellations), WellPoint paid $10 million and reinstated plans for 1,770 policy-holders who were affected by cancelled policies. The company also agreed to provide compensation for any medical debts incurred by these policy-holders.

2010 Reuters exposé

In April 2010, Reuters alleged that Wellpoint "using a computer algorithm, identified women recently diagnosed with breast cancer and then singled them out for cancellation of their policies." The software used immediately triggered fraud investigation for those recently diagnosed with the disease as the company searched for some pretext to drop their policies. Wellpoint argued that its algorithm was scanning for diagnostic codes for conditions that patients might have known about during the insurance application. The story not only caused considerable public outrage, but it also led Secretary of Health and Human Services, Kathleen Sebelius, and President Barack Obama, to call on WellPoint to end the practice.

In 2011, Anthem began cancelling policies of members who had been paying premiums with credit cards, sometimes without calling or emailing the member ahead of time.

Opposition to healthcare reform

In August 2009, Anthem, the largest for-profit insurer in California, contacted its employees and urged them to get involved to oppose healthcare reforms proposed during the Obama administration. Consumer Watchdog, a nonprofit watchdog organization in Santa Monica, asked California Attorney General Jerry Brown to investigate its claim that WellPoint had illegally pushed workers to write to their elected officials, attend town hall meetings and enlist family and friends to ensure an overhaul that would match the firm's interests. According to Consumer Watchdog, California's labor code directly prohibits coercive communications, including forbidding employers from controlling, coercing or influencing employees' political activities or affiliations. WellPoint had not been contacted by the California attorney general and had not seen any complaint.

Through 2010 and into 2011, WellPoint senior executives met monthly with executives of other major health insurers to blunt the effect of the Patient Protection and Affordable Care Act.

Premium increases in Maine

In 2009, Anthem Health Plans of Maine, a WellPoint subsidiary, sued the state of Maine for the right to increase premiums further. Since Maine licenses insurance companies through its Bureau of Insurance, Anthem needed the state's permission to raise rates. The Court disagreed with Anthem and found that, unlike with other forms of insurance, the Maine Insurance Code does not require the Superintendent to consider profits.

Rate increases in California

In February 2010, WellPoint announced that rates would increase on some Anthem Blue Cross individual policies in California by as high as 39%. The announcement resulted in an investigation by regulators from the Federal and California governments. Anthem Blue Cross gained worldwide media attention and became a poster child for the problem of rising cost of health care in the U.S. The rate increase came one year after Anthem had raised rates 68% on individual policy holders.

To explain the rate increases, some which were four times the rate of medical inflation, Anthem said the company had experienced a death spiral: the company claimed that with increased unemployment and declining wages, healthy customers dropped their insurance policies. Consequently, the remaining risk pool became sicker and thus more expensive to insure; and, in turn, prices were forced up and pushed more people out of the market.

In response to the outrage from politicians and consumers, Anthem postponed the rate increase until May 1, 2010.

Senator Dianne Feinstein of California proposed giving the Federal government of the United States authority to block insurance premium hikes that it considers to be "unjustified".

WellPoint cost reclassification

On March 17, 2010, WellPoint announced it was reclassifying some of its administrative costs as medical care costs in order to meet loss ratio requirements under the Patient Protection and Affordable Care Act, which requires insurers to spend at least 80% or 85% of customer premiums on health care services, depending on the type of plan.

2009–2010 data breach

In June 2010, Anthem sent letters to 230,000 customers in California warning them that their personal data might have been accessed online via a data breach. After a routine upgrade in October 2009, a third-party vendor stated that all security measures had been properly reinstated, when in fact they had not. As a result, personal information of thousands of coverage applicants who were under the age of 65 was exposed in the open. After a Los Angeles-area woman found that her application for coverage was publicly available, she filed a class action lawsuit against Anthem. While gathering evidence for the proceeding, the woman's lawyers downloaded some confidential customer information from Anthem's website and alerted Anthem about the breach. According to the lawyers, confidential information had remained exposed for five months. Greg Zoeller, Indiana's Attorney General, filed a lawsuit against the company seeking $300,000 in civil penalties for the company alleged failure to notify its consumers about the breach.

Denial of benefits for cancer treatment

In May 2014, Anthem Blue Cross refused to pay for the hospitalization of a Sonoma County, California man for stage four cancers, although he had paid Anthem over $100,000 in premiums. Anthem ended up paying for coverage following public outcry.

2015 data breach

On February 4, 2015, Anthem, Inc. disclosed that criminal hackers had broken into its servers and potentially stolen over 37.5 million records that contain personally identifiable information from its servers. According to Anthem, Inc., the data breach extended into multiple brands Anthem, Inc. uses to market its healthcare plans, including, Anthem Blue Cross, Anthem Blue Cross and Blue Shield, Blue Cross and Blue Shield of Georgia, Empire Blue Cross and Blue Shield, Amerigroup, Caremore, and UniCare. Healthlink was also victimized. Anthem says the medical information and financial data was not compromised. Anthem has offered free credit monitoring in the wake of the breach. According to Bloomberg News, China may be responsible for this data breach. Michael Daniel, chief adviser on cybersecurity for President Barack Obama, said he would be changing his own password. About 80 million company records were hacked, stoking fears that the stolen data could be used for identity theft. The compromised information contained names, birthdays, medical IDs, social security numbers, street addresses, e-mail addresses, employment information and income data. In June 2017, Anthem agreed to spend $115M to settle allegations that it failed to adequately protect the data of its clients, the sum was to be spent on two years of services to protect victims from identity theft. In 2019, two Chinese nationals were indicted for the breach.

"Avoidable ER program"

Beginning in 2015, Anthem has been implementing and expanding its "avoidable ER program" which means not reimbursing ER visits when the cause is not covered by the company. A few patients found out that they had been stuck with bills of over $10,000 that Anthem refused to reimburse. According to a 2013 report by the Journal of the American Medical Association, 87 percent of patients initially triaged as non-urgent ended up with a diagnosis that constituted an emergency. Critics derided the scheme, citing that it was unlawful by federal law to cover a person based on diagnosis, not symptoms. It was also considered unsafe, as it pressured patients to diagnose themselves before going to the ER.

Neglecting complaints

In 2017, the California Department of Managed Health Care fined the company $5 million for untimely response to consumer complaints. In 2019, this was settled at $2.8 million.

2019 lawsuit for coercive direct payments

In 2019, Sovereign Health pressed charges against Anthem, alleging that it was using direct payments to compel them to join Anthem's network under unfavorable terms. Sovereign owns facilities that treat people with addiction and mental health problems.

Diagnostics fraud

In March 2020, Anthem was sued by the Department of Justice. The lawsuit alleges that Anthem had submitted inaccurate diagnostics data in order to obtain increased Medicare reimbursements. In October 2022, a judge ordered Anthem to face the lawsuit.

Medicare Advantage star rating

In January 2024, Elevance Health filed a lawsuit with the Department of Health and Human Services (HHS) challenging changes in the Medicare Advantage star rating methodology. Star ratings are tied to key bonus payouts, and due to the new rating system in 2024 ratings have significantly decreased.

Finances

For the fiscal year 2017, Anthem reported earnings of US$3.843 billion, with an annual revenue of US$90.039 billion, an increase of 6.1% over the previous fiscal cycle. Anthem's shares traded at over $183 per share, and its market capitalization was valued at over US$69.1 billion in October 2018.

Recognition

The company was featured on the S&P Dow Jones Sustainability Index from 2018 to 2022, was named by Fortune as one of the 100 Best Companies to Work For, and was included on the Corporate Equality Index's list of Best Places to Work for LGBTQ Equality from 2015 to 2022.

Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗

Wikidata ↗

ELV Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy

Cena
$400.48
Kapitalizacja Rynkowa
$88.40B
P/E (TTM)
15.9
EPS (TTM)
$25.21
Przychody (TTM)
$199.12B
Stopa dywidendy
1.7%
ROE
13.3%
D/E Dług/Kapitał
0.7
Zakres 52 tyg.
$275 – $436

ELV Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok

Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS

Przychody i Zysk Netto $199.12B
10-point trend, +134.6%
2016-12-31 2025-12-31
EPS $25.21
10-point trend, +173.7%
2016-12-31 2025-12-31
Wolny przepływ pieniężny $3.17B
10-point trend, +21.1%
2016-12-31 2025-12-31
Marże 2.8%

Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?

Wskaźnik
Trend 5-letni
ELV
Mediana porównawcza
P/E (TTM)
5-point trend, -25.2%
15.9
33.8
P/S (TTM)
5-point trend, -51.9%
0.4
0.7
P/B
5-point trend, -43.3%
2.0
3.2
EV / EBITDA
5-point trend, -22.9%
12.7
Price / FCF (Cena / FCF)
5-point trend, +58.3%
27.8

Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC

Wskaźnik
Trend 5-letni
ELV
Mediana porównawcza
Operating Margin (Marża Operacyjna)
5-point trend, -33.0%
3.6%
Net Profit Margin (Marża Zysku Netto)
5-point trend, -35.5%
2.8%
0.82%
ROA
5-point trend, -28.4%
4.8%
2.2%
ROE
5-point trend, -21.8%
13.3%
6.2%
ROIC
5-point trend, -17.9%
8.0%

Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu

Wskaźnik
Trend 5-letni
ELV
Mediana porównawcza
Debt / Equity (Dług / Kapitał Własny)
5-point trend, +14.3%
0.7
99.7
Current Ratio (Wskaźnik bieżący)
5-point trend, +4.8%
1.5
1.6
Quick Ratio (Wskaźnik Szybkości)
5-point trend, +65.3%
0.2

Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni

Wskaźnik
Trend 5-letni
ELV
Mediana porównawcza
Revenue YoY (Przychody R/R)
5-point trend, +43.6%
12.5%
Revenue CAGR 3Y (Przychody CAGR 3L)
5-point trend, +43.6%
8.3%
Revenue CAGR 5Y (Przychody CAGR 5L)
5-point trend, +43.6%
10.3%
EPS YoY
5-point trend, +1.0%
-1.8%
Net Income YoY (Zysk Netto R/R)
5-point trend, -8.1%
-5.3%

Wskaźniki na akcję EPS, wartość księgowa na akcję, przepływy pieniężne na akcję, dywidenda na akcję

Wskaźnik
Trend 5-letni
ELV
Mediana porównawcza
EPS (Diluted) (EPS (Rozwodniony))
5-point trend, +1.0%
$25.21

Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności

Wskaźnik
Trend 5-letni
ELV
Mediana porównawcza
Payout Ratio (Wskaźnik Wypłaty Dywidendy)
5-point trend, +49.3%
27.0%

Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR

Stopa Dywidendy
1.7%
Wskaźnik Wypłaty Dywidendy
27.0%
CAGR dywidendy 5-letni
Data ex-dywidendyKwota
10 czerwca 2026$1,7200
10 marca 2026$1,7200
5 grudnia 2025$1,7100
10 września 2025$1,7100
10 czerwca 2025$1,7100
10 marca 2025$1,7100
5 grudnia 2024$1,6300
10 września 2024$1,6300
10 czerwca 2024$1,6300
7 marca 2024$1,6300
5 grudnia 2023$1,4800
7 września 2023$1,4800
8 czerwca 2023$1,4800
9 marca 2023$1,4800
2 grudnia 2022$1,2800
8 września 2022$1,2800
9 czerwca 2022$1,2800
9 marca 2022$1,2800
2 grudnia 2021$1,1300
9 września 2021$1,1300

ELV Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu

KUP 29 analityków
  • Mocne kupno 7 24,1%
  • Kup 12 41,4%
  • Trzymaj 10 34,5%
  • Sprzedaj 0 0,0%
  • Mocna sprzedaż 0 0,0%

12-miesięczny cel cenowy

21 analityków · 2026-08-13
Średni cel $457.00 +14,1%
Średnia cel $449.10 +12,1%

Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników

Średnie zaskoczenie
0.72%
Okres EPS Actual EPS Szacowany Niespodzianka
30 czerwca 2026 $7.45 $6.27 1.2%
31 marca 2026 $12.58 $10.93 1.6%
31 grudnia 2025 $3.33 $3.13 0.20%
30 września 2025 $6.03 $4.98 1.0%
30 czerwca 2025 $8.84 $9.04 -0.20%
31 marca 2025 $11.97 $11.50 0.47%

Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora

Ticker Kapitalizacja Rynkowa P/E Przychody r/r Marża Netto ROE Marża brutto
ELV $77.37B 13.9 12.5% 2.8% 13.3%
UNH $299.08B 25.0 11.8% 2.7% 12.0%
HUM $50.90B 26.0 10.1% 0.92% 7.0%
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9%
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
ALHC $4.03B 46.1% -0.02% -0.52%
CLOV -5.1 40.3% -4.5% -26.2%
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%

Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne

Rachunek zysków i strat 13
Dane roczne Rachunek zysków i strat dla ELV
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue 12-point trend, +169.5% $199.12B $177.01B $171.34B $156.59B $138.64B $121.87B $104.21B $92.11B $90.04B $84.86B $79.16B $73.87B
Cost of Revenue 9-point trend, +21178000000.00 $21.18B $19.75B $17.29B $13.04B $10.89B $8.95B $1.99B $0 $0 · · ·
SG&A Expense 12-point trend, +78.6% $20.98B $20.02B $20.09B $17.70B $15.92B $17.45B $13.36B $14.02B $12.65B $12.56B $12.53B $11.75B
Operating Income 12-point trend, +62.9% $7.20B $7.86B $8.50B $8.28B $7.56B $6.36B $6.00B $5.43B $4.17B $4.80B $4.75B $4.42B
Interest Expense 10-point trend, +71.5% · · $1.03B $851M $798M $784M $746M $753M $739M $723M $653M $601M
Pretax Income 12-point trend, +53.6% $6.71B $7.90B $7.71B $7.60B $8.00B $6.24B $5.99B $5.07B $3.96B $4.55B $4.63B $4.37B
Income Tax 12-point trend, -42.0% $1.05B $1.93B $1.72B $1.71B $1.85B $1.67B $1.18B $1.32B $121M $2.08B $2.07B $1.81B
Net Income 12-point trend, +120.3% $5.66B $5.98B $5.99B $5.89B $6.16B $4.57B $4.81B $3.75B $3.84B $2.47B $2.56B $2.57B
EPS (Basic) 12-point trend, +171.5% $25.28 $25.81 $25.38 $24.56 $25.26 $18.23 $18.81 $14.53 $14.70 $9.39 $9.73 $9.31
EPS (Diluted) 12-point trend, +180.4% $25.21 $25.68 $25.22 $24.28 $24.95 $17.98 $18.47 $14.19 $14.35 $9.21 $9.38 $8.99
Shares (Basic) 12-point trend, -18.8% 224,000,000 231,700,000 235,900,000 240,000,000 243,800,000 250,800,000 255,500,000 258,100,000 261,500,000 262,900,000 263,000,000 275,900,000
Shares (Diluted) 12-point trend, -21.4% 224,600,000 232,900,000 237,400,000 242,800,000 246,800,000 254,300,000 260,300,000 264,200,000 267,800,000 268,100,000 272,900,000 285,900,000
EBITDA 12-point trend, +97.9% $8.74B $9.26B $10.24B $10.13B $8.79B $7.51B $6.00B $5.43B $4.18B $4.80B $4.75B $4.42B
Bilans 26
Dane roczne Bilans dla ELV
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents 12-point trend, +341.1% $9.49B $8.29B $6.53B $7.39B $4.88B $5.74B $4.94B $3.93B $3.61B $4.08B $2.11B $2.15B
Other Current Assets 12-point trend, +262.6% $5.34B $4.70B $5.79B $5.28B $4.65B $4.06B $3.02B $2.10B $2.25B $1.78B $1.56B $1.47B
Current Assets 12-point trend, +97.2% $63.00B $58.94B $60.03B $55.62B $51.12B $45.75B $39.03B $34.32B $36.26B $34.31B $30.86B $31.95B
PP&E (Net) 12-point trend, +140.7% $4.68B $4.65B $4.36B $4.32B $3.92B $3.48B $3.13B $2.73B $2.17B $1.98B $2.02B $1.94B
PP&E (Gross) 12-point trend, +132.0% $8.73B $8.33B $7.90B $7.12B $8.26B $7.33B $6.48B $5.55B $4.37B $4.14B $4.06B $3.76B
Accum. Depreciation 12-point trend, +122.8% $4.06B $3.68B $3.54B $2.80B $4.34B $3.84B $3.35B $2.81B $2.20B $2.16B $2.04B $1.82B
Goodwill 12-point trend, +65.9% $28.34B $28.28B $25.32B $24.38B $24.23B $21.69B $20.50B $20.50B $19.23B $17.56B $17.56B $17.08B
Intangibles 12-point trend, +40.7% $11.20B $12.09B $10.27B $10.31B $10.62B $9.40B $8.67B $9.01B $8.37B $7.96B $8.16B $7.96B
Other Non-current Assets 12-point trend, +350.9% $2.31B $2.14B $1.97B $1.69B $1.72B $1.44B $1.35B $758M $565M $468M $485M $512M
Total Assets 12-point trend, +97.0% $121.49B $116.89B $108.93B $102.75B $97.46B $86.61B $77.45B $71.57B $70.54B $65.08B $61.72B $61.68B
Accounts Payable 12-point trend, +100.5% $7.32B $6.93B $6.91B $5.61B $4.97B $5.49B $4.20B $4.96B $5.02B $4.01B $3.32B $3.65B
Short-term Debt 12-point trend, -62.5% $150M $365M $225M $265M $275M $0 $700M $1.15B $1.27B $440M $540M $400M
Current Liabilities 12-point trend, +118.8% $41.03B $40.58B $41.79B $39.70B $34.88B $29.45B $23.53B $21.96B $23.36B $21.29B $19.09B $18.75B
Capital Leases 5-point trend, -38.8% $529M $658M $685M $751M $864M · · · · · · ·
Deferred Tax 12-point trend, -28.4% $2.11B $2.15B $1.97B $2.02B $2.81B $2.02B $2.23B $1.96B $1.73B $2.78B $2.63B $2.95B
Other Non-current Liabilities 12-point trend, +240.4% $3.53B $3.33B $1.74B $1.56B $1.68B $1.81B $1.42B $1.18B $925M $884M $994M $1.04B
Total Liabilities 12-point trend, +107.0% $77.47B $75.46B $69.52B $66.42B $61.29B $53.42B $45.73B $43.03B $44.04B $39.98B $38.67B $37.42B
Long-term Debt 12-point trend, +117.8% $31.90B $30.87B $24.89B $23.85B $22.76B $20.04B $19.39B $18.07B $18.66B $15.29B $15.32B $14.64B
Total Debt 12-point trend, +111.5% $32.05B $31.23B $25.12B $24.11B $23.03B $20.04B $20.09B $19.21B $19.93B $15.73B $15.86B $15.15B
Common Stock 12-point trend, -25.9% $2M $2M $2M $2M $2M $3M $3M $3M $3M $3M $3M $3M
Paid-in Capital 12-point trend, -11.2% $8.94B $8.91B $8.87B $9.08B $9.15B $9.24B $9.45B $9.54B $8.55B $8.81B $8.56B $10.06B
Retained Earnings 12-point trend, +152.5% $35.39B $33.55B $31.75B $29.65B $27.14B $23.80B $22.57B $19.99B $18.05B $16.56B $14.78B $14.01B
AOCI 12-point trend, -362.4% $-451M $-1.15B $-1.31B $-2.49B $-197M $150M $-296M $-986M $-101M $-268M $-293M $172M
Stockholders' Equity 12-point trend, +80.9% $43.88B $41.31B $39.31B $36.24B $36.09B $33.20B $31.73B $28.54B $26.50B $25.10B $23.05B $24.25B
Liabilities + Equity 12-point trend, +97.0% $121.49B $116.89B $108.93B $102.75B $97.46B $86.61B $77.45B $71.57B $70.54B $65.08B $61.72B $61.68B
Shares Outstanding 12-point trend, -17.7% 220,723,898 227,479,695 233,071,088 237,958,067 241,770,746 245,401,430 252,922,161 257,395,577 256,084,913 263,747,395 261,238,188 268,109,932
Przepływy pieniężne 18
Dane roczne Przepływy pieniężne dla ELV
Wskaźnik Trend 202520242023202220212020201920182017201620152014
D&A 8-point trend, +36.6% $1.55B $1.39B $1.75B $1.68B $1.30B $1.15B $1.13B $1.13B · · · ·
Stock-based Comp 12-point trend, +63.4% $276M $191M $289M $264M $255M $283M $294M $226M $170M $165M $148M $169M
Deferred Tax 12-point trend, -1008.8% $-279M $-374M $-602M $-115M $342M $-540M $81M $91M $-1.27B $127M $-66M $31M
Amort. of Intangibles 12-point trend, +184.3% $628M $580M $885M $767M $441M $361M $338M $358M $169M $192M $230M $221M
Other Non-cash 6-point trend, -155.9% $-2.92B $-1.38B $642M $511M $377M $5.22B · · · · · ·
Operating Cash Flow 12-point trend, +27.3% $4.29B $5.81B $8.06B $8.40B $8.36B $10.69B $6.06B $3.83B $4.18B $3.27B $4.21B $3.37B
CapEx 12-point trend, +56.2% $1.12B $1.26B $1.30B $1.15B $1.09B $1.02B $1.08B $1.21B $791M $584M $638M $715M
Investing Cash Flow 12-point trend, -37.9% $-1.34B $-5.17B $-5.57B $-4.56B $-9.64B $-7.32B $-2.79B $-1.26B $-5.08B $-514M $-1.15B $-975M
Debt Issued 12-point trend, +10.8% $2.99B $7.71B $2.57B $3.07B $3.46B $2.48B $2.47B $835M $5.46B $0 $1.23B $2.70B
Net Debt Issued 12-point trend, -13.0% $844M $6.06B $665M $1.17B $2.39B $552M $1.35B $-849M $2.64B $0 $-1.47B $970M
Stock Issued 5-point trend, +0.00 · · · · · $0 $0 $1.25B $0 $0 · ·
Stock Repurchased 12-point trend, -13.1% $2.60B $2.90B $2.68B $2.32B $1.90B $2.70B $1.70B $1.69B $2.00B $0 $1.52B $3.00B
Net Stock Activity 12-point trend, +13.1% $-2.60B $-2.90B $-2.68B $-2.32B $-1.90B $-2.70B $-1.70B $-435M $-2.00B $0 $-1.52B $-3.00B
Dividends Paid 12-point trend, +218.1% $1.53B $1.51B $1.40B $1.23B $1.10B $954M $818M $776M $705M $684M $657M $481M
Financing Cash Flow 12-point trend, +4.6% $-1.74B $1.19B $-3.35B $-1.32B $423M $-2.57B $-2.27B $-2.24B $427M $-799M $-3.09B $-1.82B
Net Change in Cash 12-point trend, +113.0% $1.20B $1.83B $-861M $2.51B $-861M $804M $1.00B $325M $-466M $1.96B $-38M $565M
Free Cash Flow 12-point trend, +19.6% $3.17B $4.55B $6.76B $7.25B $7.28B $9.67B $4.98B $2.62B $3.39B $2.62B $3.48B $2.65B
Levered FCF 10-point trend, +159.1% · · $5.97B $6.59B $6.66B $9.09B $4.38B $2.06B $2.67B $2.23B $3.12B $2.30B
Rentowność 7
Dane roczne Rentowność dla ELV
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Operating Margin 12-point trend, -39.5% 3.6% 4.4% 5.0% 5.4% 5.4% 5.2% 5.8% 5.9% 4.6% 5.7% 6.0% 6.0%
Net Margin 12-point trend, -18.4% 2.8% 3.4% 3.5% 3.9% 4.4% 3.8% 4.6% 4.1% 4.3% 2.9% 3.2% 3.5%
Pretax Margin 12-point trend, -43.0% 3.4% 4.5% 4.5% 5.0% 5.7% 5.1% 5.7% 5.5% 4.4% 5.4% 5.9% 5.9%
EBITDA Margin 12-point trend, -26.6% 4.4% 5.2% 6.0% 6.5% 6.3% 6.2% 5.8% 5.9% 4.6% 5.7% 6.0% 6.0%
ROA 12-point trend, +12.3% 4.8% 5.3% 5.7% 6.0% 6.6% 5.6% 6.5% 5.3% 5.7% 3.9% 4.2% 4.2%
ROE 12-point trend, +25.5% 13.3% 14.8% 15.8% 16.7% 17.0% 13.6% 15.2% 13.0% 14.6% 9.9% 11.1% 10.6%
ROIC 12-point trend, +21.8% 8.0% 8.2% 10.2% 10.8% 9.8% 8.8% 9.3% 8.4% 8.7% 6.4% 6.8% 6.6%
Płynność i wypłacalność 5
Dane roczne Płynność i wypłacalność dla ELV
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Current Ratio 12-point trend, -10.7% 1.5 1.5 1.4 1.4 1.5 1.6 1.7 1.6 1.6 1.6 1.6 1.7
Quick Ratio 12-point trend, +101.7% 0.2 0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.2 0.2 0.1 0.1
Debt / Equity 12-point trend, +16.9% 0.7 0.8 0.6 0.7 0.6 0.6 0.6 0.7 0.8 0.6 0.7 0.6
LT Debt / Equity 12-point trend, +20.5% 0.7 0.7 0.6 0.6 0.6 0.6 0.6 0.6 0.7 0.6 0.7 0.6
Interest Coverage 10-point trend, +12.2% · · 8.3 9.9 9.4 8.1 8.0 7.2 5.7 6.6 7.3 7.4
Efektywność 1
Dane roczne Efektywność dla ELV
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Asset Turnover 12-point trend, +37.5% 1.7 1.6 1.6 1.6 1.5 1.5 1.4 1.3 1.3 1.3 1.3 1.2
Na akcję 6
Dane roczne Na akcję dla ELV
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Book Value / Share 12-point trend, +119.8% $198.81 $181.62 $168.64 $152.58 $149.15 $135.28 $125.45 $110.88 $103.49 $95.17 $88.21 $90.45
Revenue / Share 12-point trend, +243.1% $886.58 $760.03 $721.74 $644.95 $561.75 $479.23 $400.36 $348.62 $336.22 $316.53 $290.06 $258.39
Cash Flow / Share 12-point trend, +62.1% $19.10 $24.94 $33.96 $34.59 $33.89 $42.03 $23.28 $14.49 $15.63 $11.95 $15.08 $11.78
Cash / Share 12-point trend, +435.8% $43.00 $36.43 $28.00 $31.04 $20.18 $23.39 $19.52 $15.28 $14.09 $15.45 $8.09 $8.03
Dividend / Share 10-point trend, +238.3% · · $6 $5 $5 $4 $3 $3 $3 $3 $2 $2
EPS (TTM) 12-point trend, +180.4% $25.21 $25.68 $25.22 $24.28 $24.95 $17.98 $18.47 $14.19 $14.35 $9.21 $9.38 $8.99
Stopy Wzrostu 10
Dane roczne Stopy Wzrostu dla ELV
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue YoY 5-point trend, -9.2% 12.5% 3.3% 9.4% 13.0% 13.8% · · · · · · ·
Revenue CAGR 3Y 3-point trend, -30.7% 8.3% 8.5% 12.0% · · · · · · · · ·
Revenue CAGR 5Y 10.3% · · · · · · · · · · ·
EPS YoY 5-point trend, -104.7% -1.8% 1.8% 3.9% -2.7% 38.8% · · · · · · ·
EPS CAGR 3Y 3-point trend, -89.4% 1.3% 0.97% 11.9% · · · · · · · · ·
EPS CAGR 5Y 7.0% · · · · · · · · · · ·
Net Income YoY 5-point trend, -115.3% -5.3% -0.12% 1.6% -4.3% 34.7% · · · · · · ·
Net Income CAGR 3Y 3-point trend, -114.1% -1.3% -0.97% 9.4% · · · · · · · · ·
Net Income CAGR 5Y 4.4% · · · · · · · · · · ·
Dividend CAGR 5Y 9.9% · · · · · · · · · · ·
Wycena (TTM) 17
Dane roczne Wycena (TTM) dla ELV
Wskaźnik Trend 202520242023202220212020201920182017201620152014
Revenue TTM 12-point trend, +169.5% $199.12B $177.01B $171.34B $156.59B $138.64B $121.87B $104.21B $92.11B $90.04B $84.86B $79.16B $73.87B
Net Income TTM 12-point trend, +120.3% $5.66B $5.98B $5.99B $5.89B $6.16B $4.57B $4.81B $3.75B $3.84B $2.47B $2.56B $2.57B
Market Cap 12-point trend, +129.6% $77.37B $83.92B $109.91B $122.07B $112.07B $78.80B $76.39B $67.60B $57.62B $37.92B $36.43B $33.69B
Enterprise Value 12-point trend, +114.0% $99.93B $106.86B $128.50B $138.79B $130.22B $93.09B $91.54B $82.88B $73.94B $49.57B $50.18B $46.69B
P/E 12-point trend, -0.5% 13.9 14.4 18.7 21.1 18.6 17.9 16.4 18.5 15.7 15.6 14.9 14.0
P/S 12-point trend, -14.8% 0.4 0.5 0.6 0.8 0.8 0.6 0.7 0.7 0.6 0.4 0.5 0.5
P/B 12-point trend, +26.9% 1.8 2.0 2.8 3.4 3.1 2.4 2.4 2.4 2.2 1.5 1.6 1.4
P / Tangible Book 6-point trend, -52.4% 17.8 88.9 29.6 79.0 89.5 37.5 · · · · · ·
P / Cash Flow 12-point trend, +80.4% 18.0 14.4 13.6 14.5 13.4 7.4 12.6 17.7 13.8 11.8 8.9 10.0
P / FCF 12-point trend, +92.1% 24.4 18.4 16.2 16.8 15.4 8.2 15.3 25.8 17.0 14.5 10.5 12.7
EV / EBITDA 12-point trend, +8.1% 11.4 11.5 12.5 13.7 14.8 12.4 15.3 15.3 17.7 10.3 10.6 10.6
EV / FCF 12-point trend, +79.0% 31.5 23.5 19.0 19.2 17.9 9.6 18.4 31.6 21.8 18.9 14.4 17.6
EV / Revenue 12-point trend, -20.6% 0.5 0.6 0.8 0.9 0.9 0.8 0.9 0.9 0.8 0.6 0.6 0.6
Dividend Yield 12-point trend, +38.5% 2.0% 1.8% 1.3% 1.0% 0.99% 1.2% 1.1% 1.1% 1.2% 1.8% 1.8% 1.4%
Earnings Yield 12-point trend, +0.6% 7.2% 7.0% 5.3% 4.7% 5.4% 5.6% 6.1% 5.4% 6.4% 6.4% 6.7% 7.1%
Payout Ratio 12-point trend, +44.3% 27.0% 25.2% 23.3% 20.4% 18.1% 20.9% 17.0% 20.7% 18.3% 27.7% 25.7% 18.7%
Annual Payout 12-point trend, +218.1% $1.53B $1.51B $1.40B $1.23B $1.10B $954M $818M $776M $705M $684M $657M $481M

Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat

Rachunek zysków i strat
2025-12-312024-12-312023-12-312022-12-312021-12-31
Przychody $199.12B$177.01B$171.34B$156.59B$138.64B
Marża Operacyjna % 3.6%4.4%5.0%5.4%5.4%
Zysk netto $5.66B$5.98B$5.99B$5.89B$6.16B
Rozwodniony EPS $25.21$25.68$25.22$24.28$24.95
Bilans
2025-12-312024-12-312023-12-312022-12-312021-12-31
Dług / Kapitał Własny 0.70.80.60.70.6
Wskaźnik bieżący 1.51.51.41.41.5
Wskaźnik Szybkości 0.20.20.20.20.1
Przepływy pieniężne
2025-12-312024-12-312023-12-312022-12-312021-12-31
Wolny przepływ pieniężny $3.17B$4.55B$6.76B$7.25B$7.28B

Najnowsze wiadomości Najnowsze nagłówki wspominające o tej firmie

Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku

Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów

📊

Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.

Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.

Właściciele instytucjonalni (13F) 1 772 emitenci · $54.8B łącznie · Na dzień 30 czerwca 2026

Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.

Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
Nowe pozycje Zamknięte pozycje Zwiększone Zmniejszony Zmiana liczby akcji netto
271 (+102 vs poprzedni kw.) 94 (-108 vs poprzedni kw.) 588 (+107 vs poprzedni kw.) 531 (-112 vs poprzedni kw.) +7.8M

Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.

Instytucja Wartość Akcje % z śledzonych 13F Typ
VANGUARD GROUP INC $7 274 315 633 20 751 150 13,26% Akcje
VANGUARD CAPITAL MANAGEMENT LLC $5 436 729 233 14 058 204 9,91% Akcje
STATE STREET CORP $4 032 282 885 10 426 610 7,35% Akcje
WELLINGTON MANAGEMENT GROUP LLP $3 179 014 962 8 220 244 5,80% Akcje
VANGUARD PORTFOLIO MANAGEMENT LLC $2 403 277 896 6 214 356 4,38% Akcje
Sanders Capital, LLC $2 252 711 532 5 825 024 4,11% Akcje
Artisan Partners Limited Partnership $1 771 695 984 4 581 222 3,23% Akcje
GEODE CAPITAL MANAGEMENT, LLC $1 712 764 692 4 448 634 3,12% Akcje
NORGES BANK $1 531 008 381 3 958 856 2,79% Akcje
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $779 725 026 2 016 200 1,42% Akcje
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $697 513 963 1 803 620 1,27% Akcje
Grantham, Mayo, Van Otterloo & Co. LLC $654 221 093 1 691 671 1,19% Akcje
FMR LLC $633 317 160 1 637 621 1,15% Akcje
MANUFACTURERS LIFE INSURANCE COMPANY, THE $591 084 393 1 528 416 1,08% Akcje
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $588 871 451 1 522 694 1,07% Akcje
EAGLE CAPITAL MANAGEMENT LLC $576 772 638 1 491 409 1,05% Akcje
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $511 706 827 1 323 163 0,93% Akcje
DIMENSIONAL FUND ADVISORS LP $511 575 693 1 322 824 0,93% Akcje
VANGUARD FIDUCIARY TRUST CO $461 498 831 1 193 336 0,84% Akcje
Ruane, Cunniff & Goldfarb L.P. $378 839 935 979 598 0,69% Akcje
Brave Warrior Advisors, LLC $377 790 736 976 885 0,69% Akcje
Newport Trust Company, LLC $369 294 278 954 915 0,67% Akcje
1832 Asset Management L.P. $355 109 795 918 237 0,65% Akcje
CITADEL ADVISORS LLC $293 751 600 759 578 0,54% Akcje
Capital International Investors $290 732 899 751 772 0,53% Akcje
MILLENNIUM MANAGEMENT LLC $281 369 666 727 561 0,51% Akcje
BlackRock, Inc. $268 353 881 693 905 0,49% Akcje
High Ground Investment Management LLP $262 939 273 679 904 0,48% Akcje
CANADA PENSION PLAN INVESTMENT BOARD $261 530 030 676 260 0,48% Akcje
Legal & General Group Plc $259 012 033 669 749 0,47% Akcje
ACR Alpine Capital Research, LLC $254 804 222 658 869 0,46% Akcje
Qube Research & Technologies Ltd $247 577 198 640 181 0,45% Akcje
VICTORY CAPITAL MANAGEMENT INC $240 259 106 621 258 0,44% Akcje
Swiss National Bank $239 610 173 619 580 0,44% Akcje
CAPITOLIS LIQUID GLOBAL MARKETS LLC $237 525 699 614 190 0,43% Akcje
National Pension Service $228 059 708 589 713 0,42% Akcje
GOLDMAN SACHS GROUP INC $222 913 559 576 406 0,41% Akcje
Sumitomo Mitsui Trust Group, Inc. $220 953 931 571 339 0,40% Akcje
Mitsubishi UFJ Asset Management Co., Ltd. $205 911 600 532 437 0,38% Akcje
Ninety One UK Ltd $196 567 097 508 280 0,36% Akcje
ALLIANCEBERNSTEIN L.P. $191 531 395 654 249 0,35% Akcje
FIRST TRUST ADVISORS LP $189 503 803 490 016 0,35% Akcje
Vanguard Global Advisers, LLC $183 654 210 474 890 0,33% Akcje
ENVESTNET ASSET MANAGEMENT INC $181 045 755 468 145 0,33% Akcje
8 KNOTS MANAGEMENT, LLC $179 336 122 511 585 0,33% Akcje
Focused Investors LLC $178 514 568 461 600 0,33% Akcje
Nuveen Asset Management, LLC $171 198 670 464 079 0,31% Akcje
DAVENPORT & Co LLC $171 104 235 441 940 0,31% Akcje
VANGUARD ASSET MANAGEMENT, Ltd $167 143 159 432 196 0,30% Akcje
Veritas Asset Management LLP $165 780 323 428 672 0,30% Akcje
RHUMBLINE ADVISERS $161 791 876 418 359 0,29% Akcje
California Public Employees Retirement System $157 606 784 407 537 0,29% Akcje
FIL Ltd $157 293 146 406 726 0,29% Akcje
MANNING & NAPIER ADVISORS LLC $142 522 435 367 297 0,26% Akcje
Canoe Financial LP $140 577 902 363 504 0,26% Akcje
YACKTMAN ASSET MANAGEMENT LP $131 482 399 339 985 0,24% Akcje
BANK OF AMERICA CORP /DE/ $121 697 356 314 683 0,22% Akcje
SUSQUEHANNA INTERNATIONAL GROUP, LLP $121 433 220 314 000 0,22% Opcja sprzedaży
AMERIPRISE FINANCIAL INC $119 565 700 309 171 0,22% Akcje
Swedbank AB $116 986 211 302 501 0,21% Akcje
Assenagon Asset Management S.A. $115 776 907 299 374 0,21% Akcje
M&G PLC $114 210 666 295 118 0,21% Akcje
Quantinno Capital Management LP $112 935 724 292 027 0,21% Akcje
Universal- Beteiligungs- und Servicegesellschaft mbH $112 933 654 282 040 0,21% Akcje
SUSQUEHANNA INTERNATIONAL GROUP, LLP $107 897 670 279 000 0,20% Opcja kupna
BANK OF NOVA SCOTIA $101 450 881 262 330 0,18% Akcje
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $96 843 749 330 807 0,18% Akcje
Diamond Hill Capital Management, LLC (Investment Advisor) $96 574 989 249 722 0,18% Akcje
Caisse de depot et placement du Quebec $94 418 969 244 147 0,17% Akcje
Sound Shore Management Inc /CT/ $94 150 192 243 452 0,17% Akcje
NEW YORK STATE COMMON RETIREMENT FUND $93 705 452 242 302 0,17% Akcje
AMF Tjanstepension AB $92 093 175 238 133 0,17% Akcje
BNP PARIBAS FINANCIAL MARKETS $91 136 405 235 659 0,17% Akcje
MACKENZIE FINANCIAL CORP $90 587 635 234 240 0,17% Akcje
ROYAL LONDON ASSET MANAGEMENT LTD $89 603 021 231 694 0,16% Akcje
JANE STREET GROUP, LLC $87 130 269 225 300 0,16% Opcja kupna
PZENA INVESTMENT MANAGEMENT LLC $86 849 890 224 575 0,16% Akcje
Marathon Asset Management Ltd $84 882 114 219 490 0,15% Akcje
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $84 674 534 218 950 0,15% Akcje
BARCLAYS PLC $79 161 697 204 695 0,14% Akcje
RENAISSANCE TECHNOLOGIES LLC $77 876 980 201 373 0,14% Akcje
CITADEL ADVISORS LLC $77 152 635 199 500 0,14% Opcja sprzedaży
AVIVA PLC $77 089 211 199 336 0,14% Akcje
TD Asset Management Inc $75 328 430 194 783 0,14% Akcje
Maple Rock Capital Partners Inc. $74 058 795 191 500 0,14% Akcje
Mawer Investment Management Ltd. $72 431 822 187 293 0,13% Akcje
Freestone Grove Partners LP $72 096 914 186 427 0,13% Akcje
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $71 577 149 185 083 0,13% Akcje
Zurcher Kantonalbank (Zurich Cantonalbank) $71 371 408 184 551 0,13% Akcje
Orbis Allan Gray Ltd $70 845 455 183 191 0,13% Akcje
Jefferies Financial Group Inc. $69 850 785 180 619 0,13% Akcje
CITADEL ADVISORS LLC $69 069 978 178 600 0,13% Opcja kupna
Korea Investment CORP $68 952 025 178 295 0,13% Akcje
Harvest Portfolios Group Inc. $68 795 400 177 890 0,13% Akcje
RAYMOND JAMES FINANCIAL INC $68 556 341 177 272 0,13% Akcje
LPL Financial LLC $67 831 262 175 397 0,12% Akcje
Alyeska Investment Group, L.P. $67 228 756 173 839 0,12% Akcje
Robeco Institutional Asset Management B.V. $66 324 193 171 500 0,12% Akcje
APG Asset Management N.V. $66 031 619 195 211 0,12% Akcje
ADAGE CAPITAL PARTNERS GP, L.L.C. $66 009 784 170 687 0,12% Akcje

Insiderzy spółki 92 insiderów · 55 dyrektorzy generalni · 36 dyrektorzy

Insider Rola Ostatnia aktywność Posiadane akcje Kupna 12m Sprzedaże 12m Netto 12m
Gail Boudreaux President and CEO 17 lipca 2026 P 171 976 2 0 $1 002 230
Brian T Griffin EVP & CEO, IngenioRx 3 maja 2018 M 15 863 0 0 $0
Angela F Braly Chair, President & CEO 1 marca 2012 A 476 503 0 0 $0
Brian A Sassi President & CEO Cons, EVP 7 czerwca 2011 S 60 825 0 0 $0
Dijuana K Lewis Pres & CEO CHS and EVP 20 maja 2010 M 44 107 0 0 $0
Mark L Boxer Pres & CEO of OT&GS and EVP 4 kwietnia 2008 F 42 143 0 0 $0
Joan E Herman President & CEO Cons and EVP 7 grudnia 2007 S 30 369 0 0 $0
Mark Kaye EVP & CFO 24 kwietnia 2025 S 18 977 0 0 $0
John E Gallina EVP & Chief Financial Officer 1 marca 2023 A 63 725 0 0 $0
Wayne S Deveydt EVP & Chief Financial Officer 3 marca 2016 F 57 957 0 0 $0
David C Colby Vice Chairman, CFO & EVP 4 kwietnia 2007 F 343 071 0 0 $0
Thomas R Byrd President, Anthem Specialty 26 listopada 2004 A 26 580 0 0 $0
Michael D Houk President, National Accounts 4 listopada 2004 M 18 843 0 0 $0
John M Murphy President, Specialty Business 17 maja 2004 A 20 806 0 0 $0
Caroline S Matthews Chief Operating Officer 1 grudnia 2004 A 40 471 0 0 $0
Ronald W Penczek CAO & Controller 12 czerwca 2026 S 3 740 0 1 $-148 766
Charles Morgan Kendrick JR EVP & President, Commercial 3 marca 2025 A 10 116 0 0 $0
Felicia F Norwood EVP & President,Gov Health Ben 3 marca 2025 A 31 939 0 0 $0
Ratnakar Lavu EVP, Chief Digital & Info Off 3 marca 2025 A 4 783 0 0 $0
Peter D Haytaian EVP & Pres Carelon & CarelonRx 3 marca 2025 A 26 004 0 0 $0
Blair Williams Todt EVP, CLO & CAO 3 stycznia 2025 F 15 631 0 0 $0
Gloria M Mccarthy EVP & Chief Administrative Off 24 marca 2023 S 51 435 0 0 $0
Leah Stark EVP & CHRO 30 grudnia 2021 F 12 403 0 0 $0
Jeffrey D. Alter EVP, IngenioRx & Anthem Health 1 października 2021 F 5 107 0 0 $0
Patel Prakash R EVP & President, DBG 4 września 2021 F 17 230 0 0 $0
Thomas C Zielinski EVP & General Counsel 3 listopada 2020 M 17 910 0 0 $0
Craig E Samitt EVP & President, DBG 26 lipca 2018 M 17 274 0 0 $0
Joseph Swedish Executive Chairman 5 marca 2018 S 61 419 0 0 $0
Jacquelyn H Wolf EVP & Chief HR Officer 1 marca 2018 A 3 105 0 0 $0
Jose D. Tomas EVP & Chief HR Officer 3 marca 2017 F 23 927 0 0 $0
Samuel R Nussbaum MD EVP & Chief Medical Officer 19 maja 2015 M 110 973 0 0 $0
Martin B Silverstein EVP & Chief Strategy Officer 1 maja 2015 F 23 249 0 0 $0
Kenneth R Goulet EVP, Commercial & Specialty 2 marca 2015 A 84 281 0 0 $0
Richard C Zoretic EVP, Gov Business Division 3 marca 2014 A 53 572 0 0 $0
John Cannon EVP, GC & Chief PAO 13 grudnia 2013 S 99 331 0 0 $0
Randal L Brown EVP & Chief HR Officer 4 września 2013 M 30 332 0 0 $0
Lori A Beer EVP, Specialty Businesses & IT 30 maja 2013 M 113 955 0 0 $0
Harlan A Levine EVP, CHS 31 sierpnia 2012 S 25 244 0 0 $0
Venkata R Madabhushi EVP Sr Bus & Chf Transfrmn Off 2 kwietnia 2012 A 45 237 0 0 $0
Miller Martin SVP & Chief Accounting Officer 1 marca 2011 A 29 329 0 0 $0
Fluegel M Bradley EVP, Chief Strategy Officer 5 listopada 2010 M 52 634 0 0 $0
Cynthia S Miller EVP & Chief Actuary 1 marca 2010 A 60 757 0 0 $0
Randall J Lewis EVP & Chief Compliance Officer 7 sierpnia 2009 M 13 658 0 0 $0
Jamie S Miller SVP & Chief Accounting Officer 3 marca 2008 A 25 710 0 0 $0
Alice F Rosenblatt EVP and Chief Actuary 22 stycznia 2008 S 39 265 0 0 $0
John S Watts JR EVP 7 grudnia 2007 S 108 311 0 0 $0
Marjorie W Dorr EVP 22 maja 2007 M 38 951 0 0 $0
Michael A Stocker EVP 23 października 2006 M 42 186 0 0 $0
Keith R Faller EVP 12 września 2006 M 83 290 0 0 $0
David S Helwig EVP 18 sierpnia 2006 M 55 055 0 0 $0

Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S

Posiadanie ETF-ów Posiadane przez 212 funduszy ETF

Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.

Fundusz Waga Jednostki Na dzień Źródło
GFGF · EA Series Trust 3,75% 3 541 NS 29 maja 2026 N-PORT
MDPL · Northern Lights Fund Trust IV 3,24% 5 013 NS 31 maja 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 2,78% 64 637 NS 30 kwietnia 2026 N-PORT
ABCS · EA Series Trust 2,29% 661 NS 29 maja 2026 N-PORT
FEGE · RBB Fund Trust 1,92% 94 302 NS 31 maja 2026 N-PORT
QLTY · GMO ETF Trust 1,75% 200 065 NS 31 maja 2026 N-PORT
TOLL · Tema ETF Trust 1,71% 2 139 NS 31 maja 2026 N-PORT
SRHQ · Elevation Series Trust 1,54% 7 891 NS 30 kwietnia 2026 N-PORT
BKDV · BNY Mellon ETF Trust II 1,52% 55 921 NS 30 kwietnia 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 1,35% 102 444 NS 30 kwietnia 2026 N-PORT
RXL · ProShares Trust 1,26% 2 301 NS 31 maja 2026 N-PORT
VMAX · Lattice Strategies Trust 1,25% 1 543 NS 30 kwietnia 2026 N-PORT
CURE · Direxion Shares ETF Trust 1,20% 4 402 NS 30 kwietnia 2026 N-PORT
FTA · First Trust Exchange-Traded AlphaDE… 1,12% 38 663 NS 30 kwietnia 2026 N-PORT
NUDV · Nushares ETF Trust 1,09% 1 312 NS 30 kwietnia 2026 N-PORT
AVIE · AMERICAN CENTURY ETF TRUST 1,06% 278 NS 31 maja 2026 N-PORT
MFSV · MFS Active Exchange Traded Funds Tr… 1,04% 12 508 NS 31 maja 2026 N-PORT
PY · Principal Exchange-Traded Funds 1,04% 5 907 NS 30 czerwca 2026 N-PORT
RDVI · First Trust Exchange-Traded Fund IV 0,96% 78 591 NS 30 kwietnia 2026 N-PORT
PALC · Pacer Funds Trust 0,96% 5 883 NS 30 kwietnia 2026 N-PORT
GMOV · GMO ETF Trust 0,93% 2 152 NS 31 maja 2026 N-PORT
EQIN · Columbia ETF Trust I 0,90% 6 636 NS 30 kwietnia 2026 N-PORT
ROUS · Lattice Strategies Trust 0,77% 12 014 NS 30 kwietnia 2026 N-PORT
NULC · Nushares ETF Trust 0,73% 1 105 NS 30 kwietnia 2026 N-PORT
FEUS · FlexShares Trust 0,64% 1 881 NS 30 kwietnia 2026 N-PORT
FDLO · FIDELITY COVINGTON TRUST 0,62% 23 028 NS 30 kwietnia 2026 N-PORT
COPY · RBB Fund Trust 0,60% 5 260 NS 31 maja 2026 N-PORT
FBCV · FIDELITY COVINGTON TRUST 0,60% 2 551 NS 30 kwietnia 2026 N-PORT
FAB · First Trust Exchange-Traded AlphaDE… 0,55% 2 039 NS 30 kwietnia 2026 N-PORT
FEX · First Trust Exchange-Traded AlphaDE… 0,53% 20 983 NS 30 kwietnia 2026 N-PORT
FNDX · SCHWAB STRATEGIC TRUST 0,51% 327 388 NS 31 maja 2026 N-PORT
FNDB · SCHWAB STRATEGIC TRUST 0,46% 15 433 NS 31 maja 2026 N-PORT
QUVU · Hartford Funds Exchange-Traded Trust 0,44% 2 019 NS 30 kwietnia 2026 N-PORT
DFLV · Dimensional ETF Trust 0,42% 65 620 NS 30 kwietnia 2026 N-PORT
DFUV · Dimensional ETF Trust 0,41% 155 796 NS 30 kwietnia 2026 N-PORT
JVAL · J.P. Morgan Exchange-Traded Fund Tr… 0,40% 7 882 NS 30 kwietnia 2026 N-PORT
SPXD · DBX ETF Trust 0,34% 59 NS 31 maja 2026 N-PORT
HDUS · Lattice Strategies Trust 0,31% 1 498 NS 30 kwietnia 2026 N-PORT
ESG · FlexShares Trust 0,31% 1 054 NS 30 kwietnia 2026 N-PORT
ACIO · ETF Series Solutions 0,29% 17 793 NS 30 kwietnia 2026 N-PORT
ADME · ETF Series Solutions 0,29% 2 062 NS 30 kwietnia 2026 N-PORT
SCHV · SCHWAB STRATEGIC TRUST 0,28% 111 273 NS 31 maja 2026 N-PORT
GVUS · Goldman Sachs ETF Trust 0,26% 2 725 NS 31 maja 2026 N-PORT
IQSU · New York Life Investments ETF Trust 0,26% 2 144 NS 30 kwietnia 2026 N-PORT
FBUF · Fidelity Greenwood Street Trust 0,25% 127 NS 30 kwietnia 2026 N-PORT
USSG · DBX ETF Trust 0,25% 3 671 NS 29 maja 2026 N-PORT
ESGG · FlexShares Trust 0,25% 720 NS 30 kwietnia 2026 N-PORT
JPUS · J.P. Morgan Exchange-Traded Fund Tr… 0,24% 2 806 NS 30 kwietnia 2026 N-PORT
DFSU · Dimensional ETF Trust 0,22% 12 245 NS 30 kwietnia 2026 N-PORT
SNPE · DBX ETF Trust 0,22% 15 245 NS 29 maja 2026 N-PORT